Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

[1]  B. Olsen,et al.  Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management , 2016, Diabetes technology & therapeutics.

[2]  Howard C. Zisser,et al.  Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report , 2016, Diabetes Care.

[3]  David Rodbard,et al.  Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. , 2016, Diabetes technology & therapeutics.

[4]  R. Hovorka,et al.  Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics , 2015, Diabetes/metabolism research and reviews.

[5]  J. Pickup,et al.  Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives , 2014, Diabetes Care.

[6]  K. Khunti,et al.  Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study , 2014, Diabetes Care.

[7]  D. Klonoff,et al.  Threshold-based insulin-pump interruption for reduction of hypoglycemia. , 2013, The New England journal of medicine.

[8]  W. Polonsky,et al.  What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users. , 2013, Diabetes technology & therapeutics.

[9]  B. Olsen,et al.  The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial , 2012, Diabetologia.

[10]  G. Charpentier,et al.  Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens , 2012, Diabetes Care.

[11]  H. Bilo,et al.  Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study , 2012, BMC Public Health.

[12]  Michael A. Wood,et al.  Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study , 2011, Diabetes Care.

[13]  Alex J Sutton,et al.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data , 2011, BMJ : British Medical Journal.

[14]  M. Phillip,et al.  Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes , 2011, Diabetes Care.

[15]  D. Cox,et al.  Psychometric Properties of the Hypoglycemia Fear Survey-II for Adults With Type 1 Diabetes , 2011, Diabetes Care.

[16]  S. Amiel,et al.  Hypoglycaemia: current management and controversies , 2011, Postgraduate Medical Journal.

[17]  A. Ceriello,et al.  Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells , 2011, Diabetologia.

[18]  G. Nocea,et al.  Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study , 2010, Health and quality of life outcomes.

[19]  George Dailey,et al.  Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. , 2010, The New England journal of medicine.

[20]  Darrell M. Wilson,et al.  The effect of continuous glucose monitoring in well-controlled type 1 diabetes , 2010 .

[21]  I. Sigfusdottir,et al.  Social correlates of cigarette smoking among Icelandic adolescents: A population-based cross-sectional study , 2008, BMC public health.

[22]  E. Kilpatrick,et al.  Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes , 2007, Diabetologia.

[23]  William L Clarke,et al.  Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. , 2005, Diabetes technology & therapeutics.

[24]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[25]  Workgroup on Hypoglycemia.  Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. , 2005, Diabetes care.

[26]  W. Polonsky,et al.  Assessing psychosocial distress in diabetes: development of the diabetes distress scale. , 2005, Diabetes care.

[27]  P. Cryer.  Diverse causes of hypoglycemia-associated autonomic failure in diabetes. , 2004, The New England journal of medicine.

[28]  B P Kovatchev,et al.  Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose. , 2000, The Journal of clinical endocrinology and metabolism.

[29]  U. Ungerstedt,et al.  Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison With Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions , 1997, Diabetes Care.